Literature DB >> 27863023

Skin necrosis after filler-associated vascular compromise: successful treatment with topical epidermal growth factor.

Ji Yeon Hong1, Sun Young Choi2, Kapsok Li1, Beom Joon Kim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27863023      PMCID： PMC7949755          DOI： 10.1111/iwj.12685

Source DB:  PubMed          Journal:  Int Wound J        ISSN： 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  5 in total

Review 1.  Regulation of wound healing by growth factors and cytokines.

Authors:  Sabine Werner; Richard Grose
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

Review 2.  Growth factor therapy in patients with partial-thickness burns: a systematic review and meta-analysis.

Authors:  Yi Zhang; Tao Wang; Jinguang He; Jiasheng Dong
Journal:  Int Wound J       Date:  2014-07-08       Impact factor: 3.315

3.  The effect of epidermal growth factor (EGF) conjugated with low-molecular-weight protamine (LMWP) on wound healing of the skin.

Authors:  Jin Kyu Choi; Ji-Hye Jang; Won-Hee Jang; Jaekwan Kim; Il-Hong Bae; Joonho Bae; Young-Ho Park; Beum Joon Kim; Kyung-Min Lim; Jin Woo Park
Journal:  Biomaterials       Date:  2012-08-18       Impact factor: 12.479

Review 4.  Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.

Authors:  Jorge Berlanga-Acosta; Jorge Gavilondo-Cowley; Pedro López-Saura; Tania González-López; María D Castro-Santana; Ernesto López-Mola; Gerardo Guillén-Nieto; Luis Herrera-Martinez
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

Review 5.  The epidermal growth factor receptor system in skin repair and inflammation.

Authors:  Saveria Pastore; Francesca Mascia; Valentina Mariani; Giampiero Girolomoni
Journal:  J Invest Dermatol       Date:  2007-11-29       Impact factor: 8.551
  5 in total
  1 in total

1.  Scorpion Venom Active Polypeptide May Be a New External Drug of Diabetic Ulcer.

Authors:  Ting Wan; Luocheng Li; Zhanyong Zhu; Siyang Liu; Yueqiang Zhao; Mosheng Yu
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-29       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.